How Generic Drug Tariffs Could Reshape US Trade Deficit

Episode 126 of The Trade Deficit Podcast examines the Trump administration's proposed generic drug tariffs, set to take effect in 2028 with a two-year delay. Lucas and Luna explore how this policy aims to onshore pharmaceutical production but risks widening the US trade deficit in the short term. With import prices from China hitting a 17-year high and the trade balance already at -$77.6 billion in May 2026, they break down the economics of drug imports — 80% of active pharmaceutical ingredients come from China and India — and whether tariffs can actually move supply chains. They discuss the history of drug import reliance, the role of the strong dollar in making foreign drugs cheaper, and what the two-year delay signals about political versus economic timelines. A focused look at one policy's potential to rewrite a critical piece of the trade ledger. #GenericDrugTariffs #USChinaTrade #PharmaceuticalSupplyChain #TradeDeficit #DrugImportPrices #Onshoring #IndiaPharma #ActivePharmaceuticalIngredients #StrongDollar #ImportDependence #USManufacturing #TariffPolicy #Economics #FexingoBusiness #BusinessPodcast #TradeBalance #SupplyChainResilience #HealthcareEconomics Keep every episode free: buymeacoffee.com/fexingo